https://nova.newcastle.edu.au/vital/access/ /manager/Index en-au 5 Endogenous angiotensins and catecholamines do not reduce skin blood flow or prevent hypotension in preterm piglets https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:16581 Wed 11 Apr 2018 14:11:56 AEST ]]> A pig model of the preterm neonate: anthropometric and physiological characteristics https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:14960 Wed 11 Apr 2018 13:42:54 AEST ]]> Automated cot-side tracking of functional brain age in preterm infants https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:38417 Wed 08 Sep 2021 12:33:33 AEST ]]> Relationship between very early brain structure and neuromotor, neurological and neurobehavioral function in infants born <31 weeks gestational age https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:34977 Tue 28 May 2019 13:23:49 AEST ]]> The Breathing for Life Trial: a randomised controlled trial of fractional exhaled nitric oxide (FENO)-based management of asthma during pregnancy and its impact on perinatal outcomes and infant and childhood respiratory health https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:25524 29 parts per billion (ppb), decrease in dose when FENO <19 ppb, and no change when FENO is between 19 and 29 ppb). A long acting beta agonist (LABA) will be added when symptoms remain uncontrolled. Both the control and intervention groups will report on exacerbations at a postpartum phone interview. The primary outcome is adverse perinatal outcome (a composite measure including preterm birth, intrauterine growth restriction, neonatal hospitalisation at birth or perinatal mortality), assessed from hospital records. Secondary outcomes will be each component of the primary outcome, maternal exacerbations requiring medical intervention during pregnancy (both smokers and non-smokers), and hospitalisation and emergency department presentation for wheeze, bronchiolitis or croup in the first 12 months of infancy. Outcome assessment and statistical analysis of the primary outcome will be blinded. To detect a reduction in adverse perinatal outcomes from 35 % to 26 %, 600 pregnant women with asthma per group are required. Discussion: This trial will provide evidence for the effectiveness of a FENO-based management strategy in improving perinatal outcomes in pregnant women with asthma. If successful, this would improve the management of pregnant women with asthma worldwide.]]> Thu 17 Mar 2022 14:41:14 AEDT ]]> Cytoskeletal anchoring of GLAST determines susceptibility to brain damage - an identified role for GFAP https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:3111 Sat 24 Mar 2018 08:29:09 AEDT ]]> MAP2 provides reliable early assessment of neural injury in the newborn piglet model of birth asphyxia https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:5591 Sat 24 Mar 2018 07:49:25 AEDT ]]> Inotropes do not increase cardiac output or cerebral blood flow in preterm piglets https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:29078 Sat 24 Mar 2018 07:39:58 AEDT ]]> Reduced blood volume decreases cerebral blood flow in preterm piglets https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:41277 Mon 01 Aug 2022 10:17:20 AEST ]]> Effect of Treatment of Clinical Seizures vs Electrographic Seizures in Full-Term and Near-Term Neonates: A Randomized Clinical Trial https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:53197 Fri 17 Nov 2023 11:52:45 AEDT ]]> Effect of asthma management with exhaled nitric oxide versus usual care on perinatal outcomes https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:47321 Fri 13 Jan 2023 11:06:47 AEDT ]]>